Sophont says its year-trained pathology foundation model is ready for real cancer research

iScienceLuvr · x · 2026-10-21

Sophont's founder adds context to the Holon-S1 release: after a year of training pathology and neuro foundation models, the pathology work is now good enough for real cancer research—predicting spatially resolved genes and inferring biological pathway activity from routine slides, enabling molecular interpretation of tumors that standard of care typically skips. Next step: deploying the research with clinical teams.

Related event: Sophont launches Holon-S1, predicting gene expression directly from routine pathology slides(8 posts)→

Original post →

More from Apps

Apps channel →